Linked Life Data

10653870

Source:http://linkedlifedata.com/resource/pubmed/id/10653870

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2000-2-29
pubmed:abstractText
To evaluate the efficacy and toxicity of Hyper-CVAD (fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone), a dose-intensive regimen, in adult acute lymphocytic leukemia (ALL).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
547-61
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10653870-Adolescent, pubmed-meshheading:10653870-Adult, pubmed-meshheading:10653870-Aged, pubmed-meshheading:10653870-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:10653870-Central Nervous System Neoplasms, pubmed-meshheading:10653870-Cyclophosphamide, pubmed-meshheading:10653870-Dexamethasone, pubmed-meshheading:10653870-Doxorubicin, pubmed-meshheading:10653870-Female, pubmed-meshheading:10653870-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:10653870-Humans, pubmed-meshheading:10653870-Leukemia, T-Cell, pubmed-meshheading:10653870-Male, pubmed-meshheading:10653870-Middle Aged, pubmed-meshheading:10653870-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:10653870-Risk Factors, pubmed-meshheading:10653870-Survival Analysis, pubmed-meshheading:10653870-Treatment Outcome, pubmed-meshheading:10653870-Vincristine
pubmed:year
2000
pubmed:articleTitle
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.
pubmed:affiliation
Departments of Leukemia, Biomathematics, and Radiotherapy, M.D. Anderson Cancer Center, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study